CDKN2A and hepatocellular carcinoma: These gene changes, including Trp53, Ccnd1, Ccne1, Cdkn2a and Pdl1, are in line with previous studies of HCC models and human HCC4,5,26,27 and would be expected to mediate synergistic liver damage and tumour insults.